BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 32 filers reported holding BURNING ROCK BIOTECH LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $65,006 | -72.3% | 67,017 | -37.7% | 0.00% | – |
Q2 2023 | $234,387 | -18.1% | 107,517 | +5.6% | 0.00% | – |
Q1 2023 | $286,207 | -37.8% | 101,853 | -50.2% | 0.00% | – |
Q4 2022 | $459,886 | -45.4% | 204,394 | -42.0% | 0.00% | – |
Q3 2022 | $842,000 | +37.8% | 352,414 | +67.9% | 0.00% | – |
Q2 2022 | $611,000 | -66.5% | 209,903 | +6.8% | 0.00% | – |
Q1 2022 | $1,826,000 | +10.1% | 196,590 | +12.9% | 0.00% | – |
Q4 2021 | $1,659,000 | -83.5% | 174,133 | -69.0% | 0.00% | -100.0% |
Q3 2021 | $10,046,000 | -33.9% | 561,833 | +8.9% | 0.00% | 0.0% |
Q2 2021 | $15,196,000 | – | 515,803 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,812,569 | $48,957,000 | 3.80% |
Casdin Capital, LLC | 1,730,786 | $46,749,000 | 2.77% |
Orbimed Advisors | 4,746,071 | $128,191,000 | 1.80% |
HSG Holding Ltd | 212,121 | $5,729,000 | 1.02% |
Aspex Management (HK) Ltd | 292,418 | $7,898,000 | 0.97% |
Pinz Capital Management, LP | 30,000 | $810,000 | 0.37% |
Cormorant Asset Management, LP | 250,000 | $6,753,000 | 0.26% |
Hudson Bay Capital Management LP | 537,311 | $14,512,000 | 0.25% |
Rock Springs Capital Management LP | 200,000 | $5,402,000 | 0.15% |
Monashee Investment Management LLC | 30,000 | $810,000 | 0.12% |